1071809-52-3 Usage
Uses
Used in Research and Development:
4-Fluorobenzoyl-d4 Chloride is used as a research compound for the development of new chemical entities and the study of reaction mechanisms. Its isotopically labeled nature allows for the tracking and analysis of specific chemical reactions, providing valuable insights into the behavior of molecules and their interactions.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 4-Fluorobenzoyl-d4 Chloride is used as a key intermediate in the synthesis of various drugs and drug candidates. Its unique properties enable the creation of novel molecular structures with potential therapeutic applications.
Used in Chemical Synthesis:
4-Fluorobenzoyl-d4 Chloride is used as a reagent in chemical synthesis, particularly in the preparation of fluorinated compounds. The presence of the fluorine atom in the molecule can significantly alter the properties of the resulting compounds, making them valuable for various applications in the chemical, pharmaceutical, and materials science industries.
Used in Analytical Chemistry:
4-Fluorobenzoyl-d4 Chloride is employed as a reference material in analytical chemistry, where it can be used to calibrate instruments and validate analytical methods. Its isotopically labeled nature makes it an ideal candidate for such applications, ensuring accurate and reliable results in various analytical techniques.
Check Digit Verification of cas no
The CAS Registry Mumber 1071809-52-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,7,1,8,0 and 9 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1071809-52:
(9*1)+(8*0)+(7*7)+(6*1)+(5*8)+(4*0)+(3*9)+(2*5)+(1*2)=143
143 % 10 = 3
So 1071809-52-3 is a valid CAS Registry Number.
1071809-52-3Relevant articles and documents
NOVEL PYRIMIDINECARBOXAMIDE DERIVATIVES
-
Page/Page column 10-11, (2009/07/02)
This disclosure relates to novel HIV integrase inhibitors their derivatives, pharmaceutically acceptable salts, solvates, and hydrates thereof. This disclosure also provides compositions comprising a compound of this disclosure and the use of such compositions in methods of treating HIV infections.
